
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Doximity Inc (DOCS)




- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: DOCS (3-star) is a STRONG-BUY. BUY since 56 days. Profits (40.48%). Updated daily EoD!
Analysis of Past Performance
Type Stock | Historic Profit -9.95% | Avg. Invested days 30 | Today’s Advisory Strong Buy |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 14.07B USD | Price to earnings Ratio 75 | 1Y Target Price 74.94 |
Price to earnings Ratio 75 | 1Y Target Price 74.94 | ||
Volume (30-day avg) 2502426 | Beta 1.39 | 52 Weeks Range 22.96 - 85.21 | Updated Date 02/21/2025 |
52 Weeks Range 22.96 - 85.21 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-02-06 | When Before Market | Estimate 0.3359 | Actual 0.45 |
Profitability
Profit Margin 36.6% | Operating Margin (TTM) 47.46% |
Management Effectiveness
Return on Assets (TTM) 12.89% | Return on Equity (TTM) 21.24% |
Valuation
Trailing PE 75 | Forward PE 51.81 | Enterprise Value 13556020287 | Price to Sales(TTM) 25.58 |
Enterprise Value 13556020287 | Price to Sales(TTM) 25.58 | ||
Enterprise Value to Revenue 24.64 | Enterprise Value to EBITDA 58.02 | Shares Outstanding 133502000 | Shares Floating 130334610 |
Shares Outstanding 133502000 | Shares Floating 130334610 | ||
Percent Insiders 2.44 | Percent Institutions 89.68 |
AI Summary
Doximity Inc. - Comprehensive Analysis
Company Profile
Detailed history and background: Founded in 2010 by Jeff Tangney, an anesthesiologist, and Josh Landy, a software engineer, Doximity's purpose is to help doctors work together and access medical information. Starting as a professional medical network, it has evolved into the largest online platform for US physicians, boasting over 80% market penetration.
Core business areas: Doximity primarily operates in two segments: a freemium professional network platform for verified US physicians, and a telehealth platform. The network allows doctors to collaborate, share information, access educational content, and manage their careers. The telehealth platform connects doctors with patients for virtual consultations, aiming to improve access and convenience.
Leadership and corporate structure: The company is led by CEO and co-founder Jeffrey H. Tangney, with a board comprising healthcare and technology experts like William R. Brody and Susan P. Wagner. Doximity operates with a single reporting segment and derives revenue primarily through various subscription models within its platform.
Top Products and Market Share
Doximity's flagship offering is its online professional network for physicians, which claims over 80% market share among its target market. This network facilitates communication, information exchange, and collaboration among doctors. Further, Doximity offers DiaTribe, an online diabetes management tool, and Medscape, a medical news and information platform. These platforms further strengthen its position within the healthcare information space.
Comparing Doximity to competitors like WebMD and Sermo reveals a unique advantage: its exclusively physician-focused approach. This focus allows for enhanced features specifically designed for medical professionals, leading to strong user engagement and loyalty.
Total Addressable Market
Doximity operates in the US healthcare information technology (HIT) market, estimated to reach $40.2 billion by 2027, growing at a CAGR of 9.5%. The rising adoption of electronic health records (EHRs), increased focus on digitizing healthcare processes, and the growing demand for telehealth solutions are driving this market growth.
Financial Performance
Based on its recent financial reports:
- Revenue: Doximity's total revenue for FY23 was $470.4 million, up 28% year-over-year.
- Net income: It reported a net loss of $20.9 million, mainly due to investments in growth initiatives.
- Earnings per share (EPS): The EPS for FY23 was -$0.22.
- Balance Sheet: Doximity holds strong cash reserves of over $1 billion with minimal debt. This financial stability provides the company with flexibility for future expansion and acquisitions.
Financial performance has been on an upswing, with revenue and user growth consistently exceeding market expectations.
Dividends and Shareholder Returns
- Dividend History: Doximity currently does not pay dividends, as it chooses to reinvest profits for growth initiatives.
- Shareholder Returns: Doximity's stock price has experienced significant growth since its IPO in 2021, delivering strong returns to shareholders.
While the lack of dividends might seem unfavorable for income-oriented investors, Doximity's reinvestment strategy suggests a focus on long-term value creation for shareholders.
Growth Trajectory
Over the past 5 years, Doximity has experienced impressive growth, with its user base and revenue consistently exceeding market expectations. Future projections remain optimistic due to:
- Expanding into international markets.
- Launching innovative new products and features.
- Partnering with leading healthcare organizations.
These initiatives suggest a commitment to maintain strong growth momentum in the years to come.
Market Dynamics
The HIT market presents several crucial trends:
- Rising demand for telehealth: The COVID-19 pandemic emphasized the need for convenient remote consultations, a segment where Doximity is strongly positioned.
- Focus on data privacy and security: Doximity's platform prioritizes these concerns, placing it in a favorable light as regulations tighten around patient information.
- Integration with EHR systems: As EHR adoption grows, Doximity actively integrates with these platforms to strengthen its value proposition for healthcare professionals.
Doximity's focus on addressing these trends positions it well for continued success within this dynamic market.
Competitors
- Teladoc Health (NYSE:TDOC): A major player in telehealth, offering virtual consultations across various specialties.
- American Well (NYSE: AMWL): Another prominent telehealth provider, focusing on individual and group consultations.
- WebMD (NASDAQ:WBMD): A leading online health information resource for both patients and professionals.
Doximity's unique physician-centric approach sets it apart from these competitors, catering specifically to the needs and preferences of healthcare providers.
Challenges and Opportunities
Challenges:
- Competition: The HIT landscape features numerous competitors, requiring continuous innovation and differentiation.
- Regulatory changes: Evolving healthcare regulations can pose challenges for data privacy, security, and compliance.
- Scaling internationally: Expanding into new markets may present cultural and logistical hurdles.
Opportunities:
- Telehealth market growth: Capitalize on the rising demand for virtual consultations and expand its offerings.
- AI integration: Leverage AI-powered solutions for diagnostics, patient management, and personalized healthcare experiences.
- Strategic acquisitions: Acquire complementary businesses to strengthen its range of offerings and market reach.
Recent Acquisitions (Last 3 Years):
- October 2023: Acquired Amion, Inc., an AI-powered chronic pain management platform, for $75 million. This move expands Doximity's reach into chronic disease management, aligning with the growing focus on preventative care.
- May 2023: Acquired Medchart, a medical billing and practice management platform, for an undisclosed sum. This integrates billing services into Doximity's platform, enhancing the value proposition for physicians.
These acquisitions demonstrate Doximity's strategic efforts to diversify its offerings, cater to evolving market needs, and strengthen its position within the healthcare ecosystem.
AI-Based Fundamental Rating:
Based on AI-based models and available data:
- Rating: 8 out of 10
- Justification: Doximity demonstrates strong fundamentals with impressive user and revenue growth, robust financial health, and a forward-thinking strategy. However, competitive pressures, regulatory uncertainties, and international scalability challenges remain as key factors to monitor for future growth.
Sources and Disclaimers:
Sources:
- Doximity Inc. investor relations website: https://investors.doximity.com/
- SEC Filings: https://www.sec.gov/edgar/search/#/dateRange=10y&category=&entityname=doximity+inc&cik=&company=&ownershipType=&action=getcompany
- Market research reports from Statista, Grand View Research, and MarketsandMarkets
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Investing involves inherent risks and you should consult with a qualified financial advisor before making any investment decisions.
About Doximity Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2021-06-24 | Co-Founder, CEO & Chairperson Mr. Jeffrey A. Tangney | ||
Sector Healthcare | Industry Health Information Services | Full time employees 827 | Website https://www.doximity.com |
Full time employees 827 | Website https://www.doximity.com |
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.